Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Vortioxetine (Primary)
- Indications Anxiety disorders; Depressive disorders
- Focus Therapeutic Use
- 23 Aug 2016 Planned primary completion date changed from 1 Sep 2015 to 1 Nov 2016.
- 23 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 22 Nov 2014 New trial record